PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Anti-diabetic drug springs new hope for tuberculosis patients

Drug for treating diabetes can double up as adjunct treatment for tuberculosis

2014-12-17
(Press-News.org) Singapore, Date - A more effective treatment for tuberculosis (TB) could soon be available as scientists have discovered that Metformin (MET), a drug for treating diabetes, can also be used to boost the efficacy of TB medication without inducing drug resistance.

This discovery was made by a team of international scientists led by the Singapore Immunology Network (SIgN), a research institute under the Agency for Science, Technology and Research (A*STAR), Singapore.

TB is an air-borne infectious disease caused by a bacterium called Mycobacterium tuberculosis (Mtb), which often infects the lungs. Even though drugs are available to treat the disease, TB continues to be a major threat to public health, killing close to 1.5 million people every year .

Conventional drugs used to treat TB usually adopt a pathogen-targeted strategy which attacks and kills bacteria directly. This approach has caused Mtb strains to acquire drug resistance, making existing treatments become increasingly ineffective and resulting in a pressing need to design new therapeutic strategies for the disease.

MET as an adjunct treatment for TB

The team of scientists led by SIgN began searching for drugs that could control Mtb replication indirectly. They screened FDA-approved drugs and identified MET, an old anti-diabetic drug that could defend Mtb invasion without targeting the bacteria directly. Instead, MET targets the host cells to trigger the production of a chemical which then damages Mtb and stops its replication. Such indirect, host-targeted approach is less likely to engender drug resistance. The team also discovered that MET improves the efficacy of conventional anti-TB drugs when used in combination with them.

The scientists then validated the findings with patient data provided by the Tuberculosis Clinical Unit at the Tan Tock Seng Hospital, and consequently verified that the use of MET is indeed associated with improved TB control and decreased disease severity. This anti-diabetic drug is therefore a promising adjunctive therapy that could enhance the effectiveness of existing TB treatments. As it is a drug that is currently in use, another benefit of using MET as an adjunct treatment for TB is that it is likely to shorten the time required for clinical trials.

"Using MET as an adjunct treatment for TB is very promising since this drug interferes with the biochemical pathway essential for the bacteria's survival and does not promote the development of drug resistance. MET is also a very cheap and safe drug with no adverse effect on non-diabetic patients. This would likely shorten clinical trials and we are confident that a better and affordable TB treatment will be made available soon," said lead scientists Dr Amit Singhal, Project Leader and Prof Gennaro De Libero, Principal Investigator at SIgN.

Prof Wang Yee Tang, Senior Consultant of Tan Tock Seng Hospital's Tuberculosis Control Unit, added, "Today, we are using the same standard TB treatment which was introduced more than 40 years ago. New and better treatment strategies such as this MET adjunctive therapy will definitely be welcomed by TB physicians and patients. It is also important that we continue to protect the few TB drugs we have and prevent drug resistance from emerging."

Professor Laurent Renia, Executive Director of SIgN, said, "The use of old drugs for new therapies is exciting. This study is an excellent example of innovation, made possible because of the closely knitted scientific and clinical communities in Singapore. By collaborating with our clinical partners, we are able to translate our research findings from the bench-to-bedside and ultimately impact the lives of people."

INFORMATION:

Notes to Editor:

The research findings described in this media release can be found in Science Translational Medicine, under the title, "Metformin as adjunct antituberculosis therapy" by Amit Singhal1*, Liu Jie1†, Pavanish Kumar1†, Gan Suay Hong2, Melvin Khee-Shing Leow3,4, Bhairav Paleja1, Liana Tsenova5,6, Natalia Kurepina5, Jinmiao Chen1, Francesca Zolezzi1, Barry Kreiswirth5, Michael Poidinger1,7, Cynthia Chee2, Gilla Kaplan5,8, Yee Tang Wang2, Gennaro De Libero1,9*

1Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore 138648, Singapore;
2Tuberculosis Control Unit, Tan Tock Seng Hospital, Singapore 308089, Singapore;
3Department of Endocrinology, Tan Tock Seng Hospital, Singapore 308433, Singapore;
4Singapore Institute for Clinical Sciences, A*STAR, Singapore 117609, Singapore;
5Public Health Research Institute at New Jersey Medical School, Rutgers University, Newark, NJ 07103, USA;
6New York City College of Technology, Brooklyn, NY 11201, USA;
7Department of Biological Sciences, National University of Singapore, Singapore 117543, Singapore;
8Bill & Melinda Gates Foundation, Seattle, WA 98109, USA;
9University Hospital Basel, University of Basel, Basel 4031, Switzerland;
†These authors contributed equally to this work.

Full text of the Science Translational Medicine paper can be accessed online from: http://stm.sciencemag.org/content/6/263/263ra159

For media queries and clarifications, please contact:

Tan Yun Yun
Senior Officer, Corporate Communications
Agency for Science, Technology and Research
Tel: +65 6826 6273
Email: tan_yun_yun@a-star.edu.sg

About A*STAR's Singapore Immunology Network (SIgN)

The Singapore Immunology Network (SIgN), officially inaugurated on 15 January 2008, is a research consortium under the Agency for Science, Technology and Research (A*STAR)'s Biomedical Research Council. The mandate of SIgN is to advance human immunology research and participate in international efforts to combat major health problems. Since its launch, SIgN has grown rapidly and currently includes 250 scientists from 26 different countries around the world working under 28 renowned principal investigators. At SIgN, researchers investigate immunity during infection and various inflammatory conditions including cancer and are supported by cutting edge technological research platforms and core services.

Through this, SIgN aims to build a strong platform in basic human immunology research for better translation of research findings into clinical applications. SIgN also sets out to establish productive links with local and international institutions, and encourage the exchange of ideas and expertise between academic, industrial and clinical partners and thus contribute to a vibrant research environment in Singapore.

For more information about SIgN, please visit http://www.sign.a-star.edu.sg.

About the Agency for Science, Technology and Research (A*STAR)

The Agency for Science, Technology and Research (A*STAR) is Singapore's lead public sector agency that fosters world-class scientific research and talent to drive economic growth and transform Singapore into a vibrant knowledge-based and innovation driven economy.

In line with its mission-oriented mandate, A*STAR spearheads research and development in fields that are essential to growing Singapore's manufacturing sector and catalysing new growth industries. A*STAR supports these economic clusters by providing intellectual, human and industrial capital to its partners in industry.

A*STAR oversees 18 biomedical sciences and physical sciences and engineering research entities, located in Biopolis and Fusionopolis, as well as their vicinity. These two R&D hubs house a bustling and diverse community of local and international research scientists and engineers from A*STAR's research entities as well as a growing number of corporate laboratories.

For more information on A*STAR, please visit http://www.a-star.edu.sg.



ELSE PRESS RELEASES FROM THIS DATE:

Asteroid that wiped out dinosaurs may have nearly knocked off mammals, too

Asteroid that wiped out dinosaurs may have nearly knocked off mammals, too
2014-12-17
The extinction of the dinosaurs 66 million years ago is thought to have paved the way for mammals to dominate, but a new study shows that many mammals died off alongside the dinosaurs. Metatherian mammals--the extinct relatives of living marsupials ("mammals with pouches", such as opossums) thrived in the shadow of the dinosaurs during the Cretaceous period. The new study, by an international team of experts on mammal evolution and mass extinctions, shows that these once-abundant mammals nearly followed the dinosaurs into oblivion. When a 10-km-wide asteroid struck ...

Regulation of maternal miRNAs in early embryos revealed

2014-12-17
The Center for RNA Research at the Institute for Basic Science (IBS) has succeeded in revealing, for the first time, the mechanism of how miRNAs, which control gene expression, are regulated in the early embryonic stage. The IBS researchers have verified that maternally inherited miRNAs are highly adenylated at their ends in mature oocytes and early embryos. This maternal miRNA adenylation is extensively conserved in fly, sea urchin and mouse. The researchers have also identified that the enzyme called 'Wispy' is required to catalyze miRNA adenylation and to reduce miRNA ...

Better focus at the micro world: A low-budget focus stacking system for mass digitization

Better focus at the micro world: A low-budget focus stacking system for mass digitization
2014-12-17
A team of Belgian researchers constructed a focus stacking set-up made of consumer grade products with better end results than high-end solutions and this at only a tenth of the prize of current existing systems. Because of the operational ease, speed and the low cost of the system, it is ideal for mass digitization programs involving type specimens. The study was published in the open-access journal ZooKeys. Enthusiasts or scientists, many struggle to take high quality pictures of the tiny animals of the micro world. When they eventually succeed in their effort, it is ...

Hugs help protect against stress and infection, say Carnegie Mellon researchers

2014-12-17
PITTSBURGH--Instead of an apple, could a hug-a-day keep the doctor away? According to new research from Carnegie Mellon University, that may not be that far-fetched of an idea. Led by Sheldon Cohen, the Robert E. Doherty University Professor of Psychology in CMU's Dietrich College of Humanities and Social Sciences, the researchers tested whether hugs act as a form of social support, protecting stressed people from getting sick. Published in Psychological Science, they found that greater social support and more frequent hugs protected people from the increased susceptibility ...

Substance from broccoli can moderate defects

2014-12-17
This news release is available in German. Most Hutchinson-Gilford Progeria Syndrome (HGPS) patients carry a mutation that produces a defective form of the protein lamin A. This defective protein is referred to as progerin. Normal lamin A is a key component of the matrix surrounding the DNA in the cell nucleus and plays a role in gene expression. By contrast, the defective form, progerin, is not functional but is nevertheless continuously synthesized. The result is that progerin accumulates in the nucleus and causes the cell to "age". Consequently, HGPS patients develop ...

Fine tuning your campaign

2014-12-17
Platform ecosystems are a key focus of the research carried out in the Information Systems & E-Services Group headed by Professor Alexander Benlian in the Law and Economics Department at TU Darmstadt. Ferdinand Thies and Michael Wessel decided to dedicate themselves just over a year ago primarily to the study of crowdfunding - the collective financing of social, creative or commercial projects by a community of internet users. Crowdfunding campaigns generated around five million dollars of investment in 2013 and the market is set to grow further. These types of campaign ...

AAAS analysis shows widespread looting and damage to historical sites in Syria

AAAS analysis shows widespread looting and damage to historical sites in Syria
2014-12-17
Four of six major archaeological sites in Syria have been heavily looted and damaged, according to a AAAS analysis of high-resolution satellite images that documents the extent of the destruction. The report analyzes six of the 12 sites that Syria has nominated as World Heritage Sites: Dura Europos, Ebla, Hama's Waterwheels, Mari, Raqqa, and Ugarit. A forthcoming report will analyze the additional six sites. "As we continue to study the conditions at Syria's important cultural sites, we have observed significant destruction that is largely the result of conflict. However, ...

North Atlantic signalled Ice Age thaw 1,000 years before it happened, reveals new research

2014-12-17
The Atlantic Ocean at mid-depths may have given out early warning signals - 1,000 years in advance - that the last Ice Age was going to end, scientists report today in the journal Paleoceanography. Scientists had previously known that at the end of the last Ice Age, around 14,700 years ago, major changes occurred to the Atlantic Ocean in a period known as the Bolling-Allerod interval. During this period, as glaciers melted and the Earth warmed, the currents of the Atlantic Ocean at its deepest levels changed direction. The researchers have analysed the chemistry of ...

Global carbon dioxide emissions increase to new all-time record, but growth is slowing down

2014-12-17
2013 saw global CO2 emissions from fossil fuel use and cement production reach a new all-time high. This was mainly due to the continuing steady increase in energy use in emerging economies over the past ten years. However, emissions increased at a notably slower rate (2%) than on average in the last ten years (3.8% per year since 2003, excluding the credit crunch years). This slowdown, which began in 2012, signals a further decoupling of global emissions and economic growth, which reflects mainly the lower emissions growth rate of China. China, the USA and the EU remain ...

Not just for the holidays, mistletoe could fight obesity-related liver disease

2014-12-17
Mistletoe hanging in doorways announces that the holidays are just around the corner. For some people, however, the symbolic plant might one day represent more than a kiss at Christmas time: It may mean better liver health. Researchers have found that a compound produced by a particular variety of the plant can help fight obesity-related liver disease in mice. Their study appears in ACS' Journal of Agricultural and Food Chemistry. Jungkee Kwon and colleagues note that, according to recent research, Korean mistletoe produces a number of biologically active compounds. These ...

LAST 30 PRESS RELEASES:

Study shows medical-legal partnerships aid recovery for patients with violent injuries

Learning the language of lasso peptides to improve peptide engineering

Social conflict among strongest predictors of teen mental health concerns

New framework can improve the planning stage of surgical quality improvement projects

Research shows anger, not fear, shifts political beliefs

Gale and Ira Drukier Prize in Children’s Health Research awarded to pediatric rheumatologist at Boston Children’s Hospital

UNF chemistry professor awarded NSF Grant to advance laser-based measurement technology

Research shows how Dust Bowl-type drought causes unprecedented productivity loss

Non-hibernating pikas' protein restriction tweaks their gut microbiome to help them survive the winter, when winter-active herbivores often struggle to find dietary protein

Not for hearing but for symbiosis

Disconnected cerebral hemisphere in epilepsy patients shows sleep-like state during wakefulness

Incentivizing risk to inspire investments in clean innovation for aviation

Stinkbug leg organ contains symbiotic fungi to shield eggs from parasitic wasps

Extreme, multi-year droughts drive cumulative collapse in terrestrial productivity

Researchers chart path for investors to build a cleaner aviation industry

USTC scientists uncover mystery of neurotransmission with time-resolved cryo-ET

New study finds large fluctuations in sea level occurred throughout the last ice age, a significant shift in understanding of past climate

Study reveals how bacteria in tumors drive treatment resistance in cancer

Language barriers in health care have fallen – but not online, study shows

What vibrating molecules might reveal about cell biology

UIC study of blood stem cells asks: Can we slow aging on a cellular level?

Palm oil isn’t necessarily less sustainable than other oils, say conservationists

A hitchhiker's guide to the galaxy of space immunology

Mysterious glow in Milky Way could be evidence of dark matter

Pathogenic germline variants in cancer susceptibility genes

Discrimination experiences among medical students

Pickleball-related ocular injuries among patients presenting to emergency departments

Ganoderma lucidum alleviates high-fat diet-induced hepatic lipotoxicity via modulating the unfolded protein response and endoplasmic reticulum-phagy

Circularly polarized luminescence enhancement in rare-earth MOFs due to framework chirality and host–guest energy transfer

Nickel-substituted polyoxometalate-CdS single-cluster photocatalysts for efficient plastic waste degradation coupled with H2 production

[Press-News.org] Anti-diabetic drug springs new hope for tuberculosis patients
Drug for treating diabetes can double up as adjunct treatment for tuberculosis